TY - JOUR AU - Burgaz, Sonia AU - Garcia, Concepcion AU - Gomez-Cañas, Maria AU - Muñoz, Eduardo AU - Fernandez-Ruiz, Javier PY - 2019 DO - 10.3390/molecules24152702 UR - http://hdl.handle.net/10668/14314 T2 - Molecules AB - In a recent study, we described the neuroprotective properties of VCE-003.2-an aminoquinone derivative of the non-psychotropic phytocannabinoid cannabigerol (CBG)-administered intraperitoneally (i.p.) in an inflammatory model of Parkinson's disease... LA - en PB - MDPI KW - PPAR-γ KW - Parkinson’s disease KW - VCE-003.2 KW - Cannabinoids KW - Inflammation KW - Oral formulation KW - Y receptors KW - Administration, oral KW - Animals KW - Biomarkers KW - Cannabinoids KW - Cytokines KW - Disease models, animal KW - Female KW - Immunohistochemistry KW - Inflammation mediators KW - Mice KW - Neurons KW - Neuroprotective agents KW - PPAR gamma KW - Parkinsonian disorders KW - Quinones KW - Substantia nigra TI - Development of An Oral Treatment with the PPAR-γ-Acting Cannabinoid VCE-003.2 Against the Inflammation-Driven Neuronal Deterioration in Experimental Parkinson's Disease. TY - research article VL - 24 ER -